With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...

Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

Gilead reported Q4 adjusted EPS of $1.90, exceeding estimates, with HIV sales up 16%. The company raised guidance and expects a key HIV drug launch in 2025.

The S&P 500 ended down on Wednesday after a hotter-than-expected US inflation reading added to worries that the Federal ...

US consumer prices saw their biggest jump in 18 months, backing the Federal Reserve’s stance on holding rates.

U.S. consumer prices increased in January by the most in nearly a year and a half. The surge offered a cautionary note to Trump's push for tariffs.

U.S. consumer prices increased in January by the most in nearly a year and a half, reinforcing the Fed’s message that it was ...

The S&P 500 dipped on Wednesday as a hotter-than-expected U.S. inflation reading added to worries that the Federal Reserve ...

Super Micro Computer rises after issuing strong guidance for fiscal 2026, Tesla shares trade higher after falling for five ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

The U.S. stock market saw declines after a higher-than-expected inflation report hinted that the Federal Reserve may delay interest rate cuts. Prominent companies like CVS Health rallied with strong ...